Elo Mutual Pension Insurance’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.08M Buy
12,957
+1,108
+9% +$754K 0.1% 145
2026
Q1
$9.16M Sell
11,849
-1,112
-9% -$851K 0.15% 117
2025
Q4
$10M Sell
12,961
-470
-3% -$319K 0.15% 117
2025
Q3
$7.55M Buy
13,431
+2,514
+23% +$1.42M 0.12% 138
2025
Q2
$5.73M Sell
10,917
-1,215
-10% -$678K 0.12% 145
2025
Q1
$7.69M Buy
+12,132
New +$8.34M 0.17% 108
2024
Q4
Sell
-10,300
Closed -$10.8M 535
2024
Q3
$10.8M Buy
+10,300
New +$11.5M 0.23% 82

Other funds holding REGN

Elo Mutual Pension Insurance's REGN Position: Q2 2026 in Review

Elo Mutual Pension Insurance increased its Regeneron Pharmaceuticals (REGN) stake by 9.4% in Q2 2026, buying an estimated $754K and bringing the position to 12,957 shares worth $8.08M. The position accounts for 0.1% of the portfolio, ranked #145.

Elo Mutual Pension Insurance first reported a position in REGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $10.8M in Q3 2024. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Elo Mutual Pension Insurance held 12,957 shares of Regeneron Pharmaceuticals worth $8.08M as of Q2 2026.
  • Elo Mutual Pension Insurance bought 1,108 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $754K.
  • Regeneron Pharmaceuticals made up 0.1% of Elo Mutual Pension Insurance's portfolio in Q2 2026, its #145 holding.
  • Elo Mutual Pension Insurance first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Elo Mutual Pension Insurance's Regeneron Pharmaceuticals position peaked at $10.8M in Q3 2024.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Elo Mutual Pension Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.